Unpublished results in our laboratory have found that JM4 treatment does not affect total tau levels in P301S mice (Choi et al., in review), therefore reduced tauopathy is not reflective of a general decrease in tau transgene expression. This evidence concerns the gene MAPT and tauopathy.